BABY's Big Steps...

(RTTNews) - Shares of Natus Medical Inc. (BABY), which touched an all-time high of $35.11 yesterday, have gained more than 50% in value year to date, thanks to investors paying attention to the company's organic revenue growth and improving margins.

Natus Medical is a provider of medical devices, software and services for the Newborn Care, Neurology, Sleep, Hearing and Balance markets. The company's end-user customer base includes hospitals, clinics, laboratories, physicians, nurses, audiologists, and governmental agencies.

In the U.S., the company sells its products through a direct sales organization. The products are also sold in Canada, in the French and German speaking regions of Europe, Denmark, parts of Latin America, Japan and in over 100 other countries.

A look at the performance of this medical device company over the last three years shows that there has been a year-over-year increase in revenue and earnings.

The company incurred a net loss of $11.18 million or $0.39 per share in 2011, turned around to a profit of $3.88 million or $0.13 per share in 2012, which further improved to $22.88 million or $0.74 per share in 2013.

Revenue was $232.89 million in 2011, $292.28 million in 2012 and $344 million in 2013. Gross profit margin was 56.4% in 2011, 55.9% in 2012 and 58.7% in 2013.

For the nine months ended September 30, 2014, the company's non-GAAP net income was $27.8 million or $0.86 per share on revenue of $261.8 million, and gross profit margin was 59.8%.

Looking ahead to full year 2014, Natus Medical now expects non-GAAP earnings per share range of $1.23 to $1.25 and revenue in the range of $353.8 million to $355.8 million.

BABY closed Thursday's trading at $34.31, down 0.67%.

Is BABY on your radar?